“Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics” (2024) Jurnal Kimia Valensi, 10(1), pp. 27–44. doi:10.15408/jkv.v10i1.34258.